Abstract:Several previous studies have shown that oral microbial disorders may be closely related to the occurrence and development of type 2 diabetes mellitus (T2DM). However, whether the function of oral microorganisms and their metabolites have changed in patients with T2DM who have not suffered from any oral diseases has not been reported. We performed metagenomic analyses and nontargeted metabolic analysis of saliva and supragingival plaque samples from patients with T2DM who have not suffered any oral diseases and normal controls. We found that periodontal pathogens such as Porphyromonas gingivalis and Prevotella melaninogenica were significantly enriched, while the abundances of dental caries pathogens such as Streptococcus mutans and Streptococcus sobrinus were not significantly different in patients with T2DM compared to those in normal controls. Metabolomic analyses showed that the salivary levels of cadaverine and L-(+)-leucine of patients with T2DM were significantly higher than those of normal controls, while the supragingival plaque levels of N-acetyldopamine and 3,4-dimethylbenzoic acid in patients with T2DM were significantly higher than those in the normal controls. Additionally, we identified the types of oral microorganisms related to the changes in the levels of circulating metabolites, and the oral microorganisms were involved in the dysregulation of harmful metabolites such as cadaverine and n, n-dimethylarginine. Overall, our study first described the changes in the composition of oral microorganisms and their metabolites in patients with T2DM who have not suffered any oral diseases, which will provide a direct basis for finding oral biomarkers for early warning of oral diseases in T2DM. IMPORTANCE The incidence of oral diseases in type 2 diabetic patients might increase, and the severity might also be more serious. At present, the relationship between oral microorganisms and type 2 diabetes mellitus (T2DM) has become a hot topic in systemic health research. However, whether the function of oral microorganisms and their metabolites have changed in patients with T2DM who have not suffered from any oral diseases has not been reported. We found that even if the oral condition of T2DM is healthy, their oral microbes and metabolites have changed, thus increasing the risk of periodontal disease. Our study first described the changes in the composition of oral microorganisms and their metabolites in T2DM who have not suffered any oral diseases and revealed the correlation between oral microorganisms and their metabolites, which will provide a direct basis for finding oral biomarkers for early warning of oral diseases in patients with T2DM.

NOD2 contributes to Parvimonas micra‐induced bone resorption in diabetic rats with experimental periodontitis

Periodontitis Contributes to Aberrant Metabolism in Type 2 Diabetes Mellitus Rats by Stimulating the Expression of Adipokines

Hyperglucose Contributes to Periodontitis: Involvement of the NLRP3 Pathway by Engaging the Innate Immunity of Oral Gingival Epithelium.

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

Toll-like receptor 4-mediated hyper-responsiveness of gingival epithelial cells to lipopolysaccharide in high-glucose environments.

Signaling pathways associated with immune regulation in periodontal tissues of diabetic rats

Periodontitis in Elderly Patients with Type 2 Diabetes Mellitus: Impact on Gut Microbiota and Systemic Inflammation

Effects of chronic periodontitis on renal function in OLETF rats

The effects of periodontitis on the expression of apoptosis-related proteins in pancreas of rats with Type 2 Diabetes Mellitus

Effect of Type 2 Diabetes Mellitus on Mandibular Bone Regeneration and the Expression of T Helper Cell 17/regulatory T Cell-Related Factors in Mice

Tyrosine‐protein Phosphatase Non‐receptor Type 2 Inhibits Alveolar Bone Resorption in Diabetic Periodontitis Via Dephosphorylating CSF1 Receptor

The impact of diabetes on periodontal diseases

Complement 3 Mediates Periodontal Destruction In Patients With Type 2 Diabetes By Regulating Macrophage Polarization In Periodontal Tissues

Prediabetes Enhances Periodontal Inflammation Consistent with Activation of Toll‐Like Receptor–Mediated Nuclear Factor‐κB Pathway in Rats

Dysbiosis of Oral Microbiota and Metabolite Profiles Associated with Type 2 Diabetes Mellitus

Co-culture of bone marrow stem cells and macrophages indicates intermediate mechanism between local inflammation and innate immune system in diabetic periodontitis.

Type 1 diabetes mellitus leads to gingivitis and an early compensatory increase in bone remodeling

Epigenetic changes caused by diabetes and their potential role in the development of periodontitis

Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity.

Oral microbiota in periodontitis patients with and without type 2 diabetes mellitus and their shifts after the nonsurgical periodontal therapy

Genetic analysis of impaired healing responses after periodontal therapy in type 2 diabetes: Clinical and in vivo studies